The Generation Study, which first launched in 2024, is aiming to screen 100,000 babies for more than 200 rare but treatable conditions.
More than 1,700 samples have already been collected from blood taken from the newborn’s umbilical cord shortly after birth.
The research hopes to identify rare conditions earlier, enabling timely diagnosis and treatment that could slow disease progression.
